Parathyroidectomy versus Cinacalcet in the Management of Tertiary Hyperparathyroidism: Surgery Improves Renal Transplant Allograft Survival
Sign Up to like & getrecommendations! Published in 2019 at "Surgery"
DOI: 10.1016/j.surg.2018.04.090
Abstract: Background: Renal transplant allograft function in patients with tertiary hyperparathyroidism who are treated with cinacalcet versus parathyroidectomy remains unclear. Methods: This is a retrospective, single‐center review of patients with tertiary hyperparathyroidism between 2000 and 2017.… read more here.
Keywords: tertiary hyperparathyroidism; parathyroidectomy; allograft failure; allograft ... See more keywords
Denosumab treatment for refractory hypercalcemia in a hemodialysis patient with tertiary hyperparathyroidism
Sign Up to like & getrecommendations! Published in 2023 at "Hemodialysis International"
DOI: 10.1111/hdi.13063
Abstract: The most appropriate surgical procedure for tertiary hyperparathyroidism is still controversial. Medical management may be considered in those patients with failed previous surgical intervention. There are limited medical options for tertiary hyperparathyroidism with renal dysfunction.… read more here.
Keywords: denosumab; tertiary hyperparathyroidism; hemodialysis; refractory hypercalcemia ... See more keywords
Use of denosumab to treat refractory hypercalcemia in a peritoneal dialysis patient with immobilization and tertiary hyperparathyroidism
Sign Up to like & getrecommendations! Published in 2020 at "Peritoneal Dialysis International"
DOI: 10.1177/0896860819880095
Abstract: Hypercalcemia due to excess parathyroid hormone (PTH) production is a common condition among patients with end-stage renal disease (ESRD), often referred to as tertiary hyperparathyroidism. There are limited effective medical treatment options currently available for… read more here.
Keywords: tertiary hyperparathyroidism; hyperparathyroidism; hypercalcemia; denosumab ... See more keywords
Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: A case report
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.1004624
Abstract: Introduction X-linked hypophosphatemia (XLH) is the most prevalent type of heritable fibroblast growth factor 23 (FGF23)-related hypophosphatemic rickets. Recently, anti-FGF23 antibody, burosumab, has become clinically available. We herein report a patient with adult XLH and… read more here.
Keywords: burosumab; tertiary hyperparathyroidism; adult xlh; treatment ... See more keywords
Usefulness of PET/CT with Carbon-11-Labeled Methionine in the Diagnosis of Tertiary Hyperparathyroidism
Sign Up to like & getrecommendations! Published in 2022 at "Nutrients"
DOI: 10.3390/nu15010188
Abstract: Introduction: Tertiary hyperparathyroidism (tHP) may develop in patients treated with hemodialysis or peritoneal dialysis. Parathyroidectomy may result in a significant reduction in the severity of symptoms. For the effective surgical treatment of hyperparathyroidism, proper localization… read more here.
Keywords: diagnosis; parathyroid glands; tertiary hyperparathyroidism; pet 11c ... See more keywords